The 2023 Fall Clinical Dermatology conference will take place in Las Vegas and be livestreamed from October 19 to 22; topics of interest to be covered include atopic dermatitis (AD), Janus kinase (JAK) inhibitors, and psoriasis.
The 2023 Fall Clinical Dermatology Conference will feature panels dedicated to psoriasis, Janus kinase (JAK) inhibitor treatments, and atopic dermatitis (AD) in populations of all skin colors. The conference is set to take place in Las Vegas from October 19-22, with both in-person and live stream attendance options.
The conference will start in earnest on Thursday, October 19, with panels and morning sessions starting at 8 am Pacific time. One of these panels will focus on treating patients of skin of color who have AD. Peter Lio, MD, will be leading a segment about mild to moderate AD during this panel.
“There has been an incredible revolution…we are understanding more than we’ve ever understood before about atopic dermatitis,” he said in an interview with The American Journal of Managed Care®. “…We’re in this process of refinement, and one of the areas we realized [that] has been, and I think we’re realizing this as a society overall, but it’s been really underreported [and] understudied, is looking at skin of color, because we know there are some important differences that have been unaddressed.”
The panel will not only focus on the treatment of AD in adults and pediatric patients, but also how to address the chronic skin disease in people of color with therapeutic treatment. Lio said that this panel will address why there are differences in AD in patients with darker skin, what that means, and why treatments might be different.
“We’re talking to a wide range of practitioners. Dermatologists of course are, in some ways, the main thrust, but there are many nurse practitioners and physician assistants who are taking tremendously great care of patients and are very much involved,” said Lio when discussing the target audience of the panel.
Thursday also includes a panel moderated by session chair Seemal R. Desai, MD, on the role of JAK inhibitors in dermatology and using gene expression profiling in optimizing the skin cancer journey for patients. Mona Shahriari, MD, and Elizabeth Swanson, MD, will be leading a discussion on case conversations focused the role of JAK inhibitors to start off the session, and Laura K. Ferris, MD, PhD, and Darrel S. Rigel, MD, MS, will be leading the discussion on gene expression profiling.
Friday, October 20, will also feature discussions on vitiligo, melanoma, and AD. Session chair James Q. Del Rosso, DO, will lead a session that focuses on what audiences need to know about melanoma, vitiligo, pediatric treatments in dermatology, and atopoic dermatitis, from panel participants Rigel; Desai; Adelaide A. Herbert, MD; and John Y. M. Koo, MD, respectively. Friday will also feature discussions on nonsteroidal topical therapies in psoriasis and AD, led by session chair April W. Armstrong, MD, MPH.
The pros and cons of monoclonal antibodies compared with JAK inhibitors will be a topic of conversation at a Saturday panel led by Del Rosso. Photodynamic therapy and photoprotection will also be covered during this session.
The conference is set to conclude at noon local time on Sunday after 2 sessions and a wrap-up of the conference.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More